Physician profile
Fahed Darmoch
NPI 1609282490
$1,233.90
in general payments reported to CMS, 2019-2025
12 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.27 · 2021: $208 · 2022: $86.54 · 2023: $153 · 2024: $257 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.59 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $251.56 | 2022-2025 | Repatha, Repatha |
| Abbott Laboratories | $208.24 | 2021 | |
| Edwards Lifesciences Corporation | $144.53 | 2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $144.09 | 2024-2025 | Sotyktu, Camzyos |
| Boston Scientific Corporation | $119.03 | 2024-2025 | Avvigo Guidance System, Watchman Flx |
| Biotronik INC. | $79.00 | 2023 | Acticor 7 Vr-T Dx |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Pfizer INC. | $59.77 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.63 | 2024-2025 | Lifevest |
| Angiodynamics, INC. | $46.83 | 2024 | Alphavac |
| Bayer Healthcare Pharmaceuticals INC. | $32.24 | 2025 | |
| Inspire Medical Systems, INC. | $23.71 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fahed Darmoch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.